Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab
Open Access
- 11 October 2006
- journal article
- case report
- Published by Frontiers Media SA in Transplant International
- Vol. 20 (1), 102-105
- https://doi.org/10.1111/j.1432-2277.2006.00395.x
Abstract
A 22‐year‐old patient whose primary kidney disease was focal segmental glomerulosclerosis (FSGS) developed severe recurrence of proteinuria (up to 57 g/24 h) immediately after a haploidentic living donor kidney transplantation despite pre‐operative plasmapheresis. The immunosuppressive treatment consisted of tacrolimus, mycophenolate mofetil, basiliximab and steroids. He underwent 10 plasmapheresis sessions in the first 3‐week post‐transplantation. In addition, he received 2 i.v. doses of rituximab (RTX) 600 mg (375 mg/m2) on days 7 and 15. Proteinuria decreased below nephrotic range at day 14 and serum creatinine returned progressively to normal values. A short course of oral ciclophosphamide (100 mg/j) was administrated between days 22 and 40 and three additional plasmapheresis sessions on days 34, 39 and 49. This strategy allowed obtaining sustained full remission of the nephrotic syndrome (NS) and excellent graft function, which persists over 2 years after transplantation. No notable adverse events related to RTX or plasmapheresis were observed. This case suggests that RTX associated with plasmapheresis may be an effective treatment of recurrent NS because of FSGS.Keywords
This publication has 27 references indexed in Scilit:
- Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 casesBlood, 2005
- Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndromePediatric Nephrology, 2005
- Tolerability and safety of rituximab (MabThera®)Cancer Treatment Reviews, 2005
- The Biology of CD20 and Its Potential as a Target for mAb TherapyPublished by S. Karger AG ,2004
- Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndromeClinical Nephrology, 2003
- Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in childrenTransplantation, 2003
- Chimaeric anti‐CD20 monoclonal antibody (rituximab) in post‐transplant B‐lymphoproliferative disorder following stem cell transplantation in childrenBritish Journal of Haematology, 2001
- Extracorporeal Plasma Treatment in Primary and Recurrent Focal Segmental Glomerular Sclerosis: A ReviewTherapeutic Apheresis and Dialysis, 2001
- RECURRENT NEPHROTIC SYNDROME FOLLOWING RENAL TRANSPLANTATION IN PATIENTS WITH FOCAL GLOMERULOSCLEROSISTransplantation, 1991
- Serum IgE in Primary Glomerular Diseases and Its Clinical SignificanceNephron, 1988